Drug Profile
Enoxaparin sodium biosimilar - Rovi
Alternative Names: Enoksaparin Rovi; Enoxaparin Becat; Enoxaparin biosimilar - Rovi; Enoxaparin Rovi; Enoxaparina Rovi; Enoxaparine Becat; LosminaLatest Information Update: 15 May 2019
Price :
$50
*
At a glance
- Originator Rovi
- Class Anti-ischaemics; Antithrombotics; Ischaemic heart disorder therapies; Low molecular weight heparins
- Mechanism of Action Factor Xa inhibitors; Thrombin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Deep vein thrombosis; Myocardial infarction; Unstable angina pectoris